Ziegler Capital Management, LLC Eagle Pharmaceuticals, Inc. Transaction History

Ziegler Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	SELL	$15.21 - $22.88 $1,673 - $2,516	-110 Reduced 0.61%	17,804 $280,000
Q2 2023 Jul 25, 2023	BUY	$17.74 - $31.87 $55,331 - $99,402	3,119 Added 21.08%	17,914 $348,000
Q1 2023 May 04, 2023	BUY	$25.06 - $34.09 $3,583 - $4,874	143 Added 0.98%	14,795 $419,000
Q4 2022 Jan 24, 2023	SELL	$24.98 - $39.77 $90,377 - $143,887	-3,618 Reduced 19.8%	14,652 $0
Q3 2022 Oct 25, 2022	SELL	$26.42 - $47.12 $2,800 - $4,994	-106 Reduced 0.58%	18,270 $483,000
Q2 2022 Jul 21, 2022	BUY	$41.26 - $51.35 $270,376 - $336,496	6,553 Added 55.43%	18,376 $816,000
Q4 2021 Feb 09, 2022	SELL	$45.82 - $56.9 $185,250 - $230,046	-4,043 Reduced 25.48%	11,823 $602,000
Q3 2021 Oct 27, 2021	SELL	$43.79 - $55.78 $23,208 - $29,563	-530 Reduced 3.23%	15,866 $885,000
Q2 2021 Jul 21, 2021	BUY	$36.86 - $44.5 $604,356 - $729,622	16,396 New	16,396 $702,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ziegler Capital Management, LLC with notifications on news.